Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Kallyope

    Client Virtual Booth

    KALLYOPE

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Kallyope
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    430 East 29th Street, 10th Floor | New York, NY 10016
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kallyope.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kallyope/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Kallyope Enters Phase 2 With First-in-class Oral Approach
    Kallyope Enters Phase 2 With First-in-class Oral Approach

    https://www.businesswire.com/news/home/20230927390827/en

    BUSINESSWIRE
    27 Sep 2023
    Share Share
    Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors
    Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors

    https://www.businesswire.com/news/home/20230606005244/en

    BUSINESSWIRE
    06 Jun 2023
    Share Share
    Kallyope, Pioneers in Drug Discovery via Gut-Brain Axis, With New Appointments
    Kallyope, Pioneers in Drug Discovery via Gut-Brain Axis, With New Appointments

    https://www.businesswire.com/news/home/20220706005265/en

    BUSINESSWIRE
    06 Jul 2022
    Share Share
    Sosei Heptares and Kallyope Enter Collaboration for Novel GI GPCR Targets
    Sosei Heptares and Kallyope Enter Collaboration for Novel GI GPCR Targets

    https://www.globenewswire.com/news-release/2022/05/17/2444528/0/en/Sosei-Heptares-and-Kallyope-Enter-Collaboration-to-Identify-and-Validate-Novel-Gastrointestinal-GPCR-Targets-for-Drug-Discovery.html

    GLOBENEWSWIRE
    17 May 2022
    Share Share
    Kallyope delays IPO to snag $236M series D for 22 programs
    Kallyope delays IPO to snag $236M series D for 22 programs

    https://www.bioworld.com/articles/516083-kallyope-raises-236m-for-drugs-targeting-gut-brain-axis?v=preview

    M. Fitzhugh BIOWORLD
    16 Feb 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search